We use cookies to make your experience better. To comply with the new e-Privacy directive, we need to ask for your consent to set the cookies. Learn about our cookie policy.
Revvity LSDX Digoxin; -; 250uCi (9.25MBq)
List Price $2,505.80 Your Price $2,505.80
Revvity LSDX Digoxin, [3H(g)]-, 250uCi (9.25MBq) - PEGSK (Additional S&H or Hazmat Fees May Apply)
NETA PART: PEGSK-NET222250UC
MFG.PART: NET222250UC
UNSPSC: 12142207
Manufacturer: Revvity
Revvity 250 Μci Quantities Of [3h(g)]-Digoxin Are Available For Your Research. Application Of [3h] Digoxin Can Be Found In: Expressing Human P-Glycoprotein (Probing Trans- And Cis-Inhibitory Effects On Efflux) In Pharmacology, Development, Validation And Utility Of An In Vitro Technique For Assessment Of Potential Clinical Drug-Drug Interactions Involving P-Glycoprotein, Inhibition Of P-Glycoprotein-Mediated Transport, Etc.S - PEGSK (Additional S&H Or Hazmat Fees May Apply)
| SKU | PEGSK-NET222250UC |
|---|---|
| Supplier Part Number | NET222250UC |
| UM | PK |
| UNSPSC | 12142207 |
| Manufacturer | Revvity |
| CountryOfOrigin | United States |
| ProductLine | PEGSK |
| Qty | 250 |
| MinOrderQty | 1 |
| Weight | 7.000000 |
| Lead Time | 6 |
| Hazardous | Y |
| CAS Number | 20830-75-5 |
| Energy Star | No |
| Green | No |
| HarmonizationCode | 2844400050 |
| Controlled | N |